Leva Scientific company logo

Elevating R&D from Concept to Clarity

Strategic R&D Advisory | Cambridge, MA

Leva Scientific provides the strategic R&D guidance and data-driven insights needed to de-risk technology, accelerate development, and achieve critical milestones with confidence. Refine concepts, validate technology, and make informed decisions faster.

From Scientific Vision to Commercial Viability

Icon: map, representing Strategic Clarity provided by Leva Scientific

Strategic Clarity

Develop a robust R&D roadmap that aligns with your corporate goals, IP strategy, and market landscape. I provide the executive-level perspective needed to make critical go/no-go decisions with confidence.

Icon: shield with checkmark, representing Technical Confidence provided by Leva Scientific

Technical Confidence

De-risk your core technology by identifying and solving critical challenges before they derail your timeline. Leverage my deep expertise to validate your platform's architecture and ensure its scientific and commercial feasibility.

Icon: currency symbol, representing Capital Efficiency enabled by Leva Scientific

Capital Efficiency

Achieve your milestones faster and with less wasted effort. I help you focus resources on what matters most, converting complex technical data into a clear narrative for investors, partners, and leadership.

How I Help: Areas of Advisory Focus

  • R&D Roadmap & IP Strategy: Aligning your technology development with long-term corporate goals, competitive landscape, and intellectual property strategy.

  • Technical Due Diligence: Providing deep technical assessment for venture capital, M&A, and strategic partnerships to validate technology and identify potential risks.

  • Platform De-risking & Validation: Designing and guiding key experiments to address critical scientific and engineering challenges, ensuring your core technology is robust and scalable.

  • Investor & Board Communication: Converting complex technical data into clear, compelling narratives that build confidence and secure funding.

Leva Scientific is a selective advisory practice built on a foundation of operational R&D leadership in the medtech and life sciences sectors, dedicated to deep, high-impact engagements.

About Me

Kyle C. Smith, PhD

I build deep-tech ventures from founding concept to commercial launch. Twice I've taken novel microfluidic platforms from a lab bench to a manufactured product — building the R&D organizations, securing the funding, forging the partnerships, and navigating the pivots that turn breakthrough science into working businesses. My advisory work draws directly from this operational experience.My expertise in medtech and life sciences — built on a foundation of research at MIT and MGH — was honed through leading ventures from the lab bench to commercial scale. Whether it's architecting an IP portfolio, conducting technical due diligence, or validating a novel technology platform, I bring a hands-on, operator-first perspective to every engagement.My approach is first-principles and predictive — I'd rather kill a bad idea in simulation than burn cash proving it in the lab. I build capital-efficient roadmaps proven across both deep-tech hardware and bootstrapped service models.

Proof of Performance

My expertise is built on a track record of building complex technology into tangible business value. The following are representative examples of the results I deliver.

Secured $38M in Funding & Launched First Commercial Product

As the first employee and founding team member at MicroMedicine, I built the R&D organization from scratch, led the development of the Sorterra™ cell processing platform, and drove the execution that secured $38M in milestone-based funding — from spin-out to commercial launch.

Engineered a Capital-Efficient Business Pivot
 

As Co-Founder and CTO of BendBio, I architected a strategic pivot from a capital-intensive instrument model to a high-margin consumables model, engineering a business structure that secured first revenues and preserved 100% founder equity through a partnership-funded model.

Created Foundational IP Anchoring a $35M Strategic Partnership

At Massachusetts General Hospital, I invented the foundational microfluidic technologies that launched multiple spinout companies and anchored a $35M strategic R&D partnership with Johnson & Johnson for next-generation diagnostic devices.


Let's Connect

© 2026 Kyle C. Smith | Cambridge, MA | All Rights Reserved